Growth Metrics

Item 9 Labs (INLB) EBIT Margin (2016 - 2023)

Item 9 Labs' EBIT Margin history spans 12 years, with the latest figure at 59.06% for Q2 2023.

  • For Q2 2023, EBIT Margin rose 1897.0% year-over-year to 59.06%; the TTM value through Jun 2023 reached 47.93%, up 10772.0%, while the annual FY2022 figure was 30.01%, 5555.0% up from the prior year.
  • EBIT Margin reached 59.06% in Q2 2023 per INLB's latest filing, down from 22.89% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 381.97% in Q3 2022 to a low of 629.01% in Q3 2019.
  • Average EBIT Margin over 5 years is 37.7%, with a median of 38.13% recorded in 2021.
  • Peak YoY movement for EBIT Margin: crashed -55764bps in 2019, then soared 82449bps in 2020.
  • A 5-year view of EBIT Margin shows it stood at 78.41% in 2019, then surged by 85bps to 12.04% in 2020, then crashed by -187bps to 34.51% in 2021, then rose by 8bps to 31.68% in 2022, then tumbled by -86bps to 59.06% in 2023.
  • Per Business Quant, the three most recent readings for INLB's EBIT Margin are 59.06% (Q2 2023), 22.89% (Q1 2023), and 31.68% (Q4 2022).